Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.18 HKD | +0.39% | +0.78% | -25.11% |
05-13 | InnoCare Logs Loss in Q1 | MT |
03-29 | InnoCare Pharma Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- 9969 Stock
- News InnoCare Pharma Limited
- Official Publications